The diabetes drug Actos could increase a person's risk of developing bladder cancer. Health Canada and the drug manufacturer, Takeda Canada Inc., stated.
This announcement was issued two days after the U.S. Food and Drug administration issued a similar warning.
Health Canada stated that the drug's labelling will be altered to reflect the possible risk.
Actos is the brand name for pioglitazone used for treatment of Type 2 diabetes . Its sister drug is Avandia, once upon a time a widely used diabetes drug which lost favour after research discovered it increased its users likelihood of developing heart disease .
A ten year old study into the effects of this drug indicate it does increase the risk of heart disease.
Presently in Ontario Actos is not on the list of drugs that doctors freely prescribe; it has been placed in the "exceptional access" list which means that it needs approval to be prescribed.
Dr. David Juurlink, head of the division of clinical pharmacology at the University of Toronto, stated that currently there is minimal need to take this this drug, unless a patient on it has fared extremely well on it in the past.
Diabetes Drug Could Increase Risk of Bladder Cancer
Mon, 23 Apr 2012
Recommended linksDiabetic Travel Insurance for a Single Person
Diabetic Travel Insurance for a Couple
Diabetic Travel Insurance for a Family
Diabetic Travel Insurance for a Single Parent
Long Haul Travel and Diabetes
Equipment You Need to Take Abroad
Diabetes Care in Ten Minutes
Weekly Injected Diabetes Drug is Approved by the FDA
Can Red Wine Pill Help Diabetes and Cancer
Diabetes Can Cause Deafness in Women
Gestational Diabetes Risk Increased by High Intake of Animal Fat
Numbers of Diabetes Related Amputations Drop Dramatically
High Diabetes and Pre Diabetes Rates Among Men in Ireland
Why Coffee Lowers Risk of Diabetes
Kings College and Cardiff University make Type 1 Diabetes Discovery
Does Coffee Help with Diabetes
Statins Associated with Risk of Diabetes
24,000 Deaths Related to Diabetes could be Avoided Each Year
Low Vitamin D Related to Risk of Type 2 Diabetes